Clinical Trial Update: JC Virus Antibody Study of Participants With Relapsing Forms of MS Receiving Treatment With Natalizumab

View source ↗

Summary

Clinical trial update describing a completed study that evaluates JC virus antibody status in participants with relapsing multiple sclerosis treated with natali…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing Multiple Sclerosis

Drugs mentioned

• Tysabri (Natalizumab)

Snippet

Sponsor: Biogen | Conditions: Relapsing Multiple Sclerosis | Status: COMPLETED